Clinical trial
A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)
NCT00437437 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00437437 |
|---|---|
| Title | A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) |
| Official title | Phase I Study to Determine the Effect of a High Fat Meal on the Pharmacokinetics of BMS-540215, the Active Metabolite of Brivanib Alaninate in Subjects With Advanced or Metastatic Solid Tumors |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | Brivanib |
| Enrollment | 29 |
| Start date | May 1, 2000 |
| Primary completion | May 1, 2008 |
| Completion | Feb 1, 2013 |
| First posted | Feb 21, 2007 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: